USFDA approves Inclisiran to lower LDL cholesterol Roshni Dhar25 Dec 2021 12:28 PM ISTUS Food and Drug Administration has approved inclisiran (Leqvio; Novartis) for lowering LDL cholesterol levels.Inclisiran is a small interfering RNA...
FDA approves inclisiran to lower LDL cholesterol and keep it low with two doses a year Hina Zahid24 Dec 2021 10:30 AM ISTEast Hanover - US Food and Drug Administration has approved inclisiran (Leqvio; Novartis) for lowering LDL cholesterol levels.Inclisiran is a small...
Novartis proposal to market Inclisiran with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team24 Oct 2021 11:30 AM ISTNew Delhi: Rejecting Novartis Healthcare's proposal to import and market Inclisiran Solution for Injection with a local clinical trial waiver,...
Novartis inclisiran gets complete USFDA response letter for treating hyperlipidemia Ruchika Sharma21 Dec 2020 1:01 PM ISTThe FDA stated that the agency cannot approve the NDA by the Prescription Drug User Fee Act(PDUFA) action date of December 23, 2020, due to unresolved...
New analysis confirms LDL-C lowering effect of investigational inclisiran: ESC update Hina Zahid1 Sept 2020 11:56 AM ISTEAST HANOVER, N.J. - A post-hoc analysis of pooled data from the Phase III ORION-10 and -11 trials evaluatedthe individual responses of patients on...
